These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 21444856

  • 21. Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy.
    Elmansy HM, Elzayat EA, Sampalis JS, Elhilali MM.
    Urology; 2009 Nov; 74(5):1105-10. PubMed ID: 19773035
    [Abstract] [Full Text] [Related]

  • 22. Chromogranin A and biochemical progression-free survival in prostate adenocarcinomas submitted to radical prostatectomy.
    Alessandro S, Vincenzo G, Maria AG, Stefano S, Alessandro G, Salvatore M, Vincenzo T, Franco DS.
    Endocr Relat Cancer; 2007 Sep; 14(3):625-32. PubMed ID: 17914093
    [Abstract] [Full Text] [Related]

  • 23. Rising PSA after prostate surgery may guide subsequent treatment.
    Health News; 1999 Jun 25; 5(8):6. PubMed ID: 10397034
    [No Abstract] [Full Text] [Related]

  • 24. Prostate-specific antigen (PSA) in the monitoring of prostate cancer after radical prostatectomy and external beam radiation.
    Schaefer U, Witt F, Schueller P, Micke O, Willich N.
    Anticancer Res; 2000 Jun 25; 20(6D):4989-92. PubMed ID: 11326654
    [Abstract] [Full Text] [Related]

  • 25. Free/Total PSA (F/T ratio) kinetics in patients with clinically localized prostate cancer undergoing radical prostatectomy.
    Gregorakis AK, Malovrouvas D, Stefanakis S, Petraki K, Scorilas A.
    Clin Chim Acta; 2005 Jul 24; 357(2):196-201. PubMed ID: 15936010
    [Abstract] [Full Text] [Related]

  • 26. Role of free to total prostate specific antigen ratio in serum in the diagnosis of prostatic enlargement.
    Bhuiyan AK, Kibria SA, Subhan SS.
    Bangladesh Med Res Counc Bull; 2004 Aug 24; 30(2):51-9. PubMed ID: 15813483
    [Abstract] [Full Text] [Related]

  • 27. Ratio of free-to-total prostate specific antigen correlates with tumor volume in patients with increased prostate specific antigen.
    Grossklaus DJ, Shappell SB, Gautam S, Smith JA, Cookson MS.
    J Urol; 2001 Feb 24; 165(2):455-8. PubMed ID: 11176395
    [Abstract] [Full Text] [Related]

  • 28. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U, Scattoni V, Freschi M, Briganti A, Salonia A, Gallina A, Colombo R, Karakiewicz PI, Rigatti P, Montorsi F.
    Eur Urol; 2008 Jul 24; 54(1):118-25. PubMed ID: 18314255
    [Abstract] [Full Text] [Related]

  • 29. Introduction: rising PSA after radical prostatectomy: a burning issue.
    Boccon-Gibod L.
    Semin Urol Oncol; 1999 Aug 24; 17(3):125-6. PubMed ID: 10462313
    [No Abstract] [Full Text] [Related]

  • 30. PSA velocity and prostate cancer.
    Bianco FJ, Kattan MW, Scardino PT.
    N Engl J Med; 2004 Oct 21; 351(17):1800-2; author reply 1800-2. PubMed ID: 15499669
    [No Abstract] [Full Text] [Related]

  • 31. Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy.
    Pound CR, Christens-Barry OW, Gurganus RT, Partin AW, Walsh PC.
    J Urol; 1999 Oct 21; 162(4):1337-40. PubMed ID: 10492192
    [Abstract] [Full Text] [Related]

  • 32. Prostate-specific antigen failure within 2 years of radical prostatectomy predicts overall survival.
    Hachiya T, Ichinose T, Hirakata H, Kawata N, Okada K, Takimoto Y.
    Int J Urol; 2006 Apr 21; 13(4):362-7. PubMed ID: 16734851
    [Abstract] [Full Text] [Related]

  • 33. Prostate cancer with low PSA levels.
    Datta MW, Berman JJ, Dhir R.
    N Engl J Med; 2004 Oct 21; 351(17):1802-3. PubMed ID: 15499672
    [No Abstract] [Full Text] [Related]

  • 34. Prevalence and clinical significance of prostate cancer among 12,682 men with normal digital rectal examination, low PSA levels (< or =4 ng/ml) and percent free PSA cutoff values of 15 and 20%.
    Pepe P, Panella P, Savoca F, Cacciola A, D'Arrigo L, Dibenedetto G, Pennisi M, Aragona F.
    Urol Int; 2007 Oct 21; 78(4):308-12. PubMed ID: 17495487
    [Abstract] [Full Text] [Related]

  • 35. Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy.
    Castellucci P, Fuccio C, Nanni C, Santi I, Rizzello A, Lodi F, Franceschelli A, Martorana G, Manferrari F, Fanti S.
    J Nucl Med; 2009 Sep 21; 50(9):1394-400. PubMed ID: 19690023
    [Abstract] [Full Text] [Related]

  • 36. [Prostatic specific antigen: role and significance in urologic practice].
    Manolović D, Pejcić T, Milović N.
    Srp Arh Celok Lek; 1994 Sep 21; 122(5-6):171-3. PubMed ID: 17977420
    [Abstract] [Full Text] [Related]

  • 37. [Advanced prostate cancer with normal serum prostate-specific antigen values].
    Komura T, Yamagiwa K, Ogura H, Kohjimoto Y, Ohkawa T, Inagaki T, Ebisuno S, Senzaki A.
    Hinyokika Kiyo; 1998 May 21; 44(5):303-6. PubMed ID: 9656099
    [Abstract] [Full Text] [Related]

  • 38. Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up.
    Chaplin BJ, Wildhagen MF, Schroder FH, Kirkels WJ, Bangma CH.
    Eur Urol; 2005 Dec 21; 48(6):906-10. PubMed ID: 16126322
    [Abstract] [Full Text] [Related]

  • 39. Prostate specific antigen progression rates after radical prostatectomy or radiation therapy for localized prostate cancer.
    Fowler JE, Pandey P, Braswell NT, Seaver L.
    Surgery; 1994 Aug 21; 116(2):302-5; discussion 305-6. PubMed ID: 7519363
    [Abstract] [Full Text] [Related]

  • 40. Investigative clinical study on prostate cancer part II: on the role of the pretreatment total PSA to free testosterone ratio as a marker assessing prostate cancer prognostic groups after radical retropubic prostatectomy.
    Porcaro AB, Monaco C, Romano M, Petrozziello A, Rubilotta E, Lacola V, Sava T, Ghimenton C, Caruso B, Antoniolli SZ, Migliorini F, Comunale L.
    Urol Int; 2010 Aug 21; 85(2):152-8. PubMed ID: 20616526
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.